SF
NVAX icon

Synovus Financial’s Novavax NVAX Stock Holding History

Synovus Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25
Closed – – 1943
2020
Q1 		$0 Buy
+25
New +$212 ﹤0.01% 2193
2016
Q4 		– Sell
-50
Closed -$2K – 1088
2016
Q3 		$2K Hold
50
– – ﹤0.01% 982
2016
Q2 		$7K Hold
50
– – ﹤0.01% 888
2016
Q1 		$5K Buy
+50
New +$5.36K ﹤0.01% 914
2015
Q4 		– Sell
-3
Closed – – 1033
2015
Q3 		$0 Buy
+3
New +$673 ﹤0.01% 998

Other funds holding NVAX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Synovus Financial's NVAX Position: Q2 2020 in Review

Synovus Financial sold out of Novavax (NVAX) in Q2 2020, closing a stake of 25 shares.

Synovus Financial first reported a position in NVAX in Q3 2015 and held it in 5 quarters. The position peaked at $7K in Q2 2016. 213 funds tracked by Wall St. Rank hold NVAX as of Q2 2020.

  • Synovus Financial reported no remaining Novavax position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 25 Novavax shares in Q2 2020.
  • Synovus Financial first reported a position in Novavax in Q3 2015 and held it in 5 quarters.
  • Synovus Financial's Novavax position peaked at $7K in Q2 2016.
  • 213 funds tracked by Wall St. Rank held Novavax as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.